These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 32197732)

  • 41. Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population.
    Delgado-Herrera L; Lasch K; Zeiher B; Lembo AJ; Drossman DA; Banderas B; Rosa K; Lademacher C; Arbuckle R
    Therap Adv Gastroenterol; 2017 Sep; 10(9):673-687. PubMed ID: 28932269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Andresen V; Montori VM; Keller J; West CP; Layer P; Camilleri M
    Clin Gastroenterol Hepatol; 2008 May; 6(5):545-55. PubMed ID: 18242143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times Diary.
    Wright-McNaughton M; Ten Bokkel Huinink S; Frampton CMA; McCombie AM; Talley NJ; Skidmore PML; Gearry RB
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00103. PubMed ID: 31800544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse childhood experiences are associated with irritable bowel syndrome and gastrointestinal symptom severity.
    Park SH; Videlock EJ; Shih W; Presson AP; Mayer EA; Chang L
    Neurogastroenterol Motil; 2016 Aug; 28(8):1252-60. PubMed ID: 27061107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome.
    Larsson MB; Tillisch K; Craig AD; Engström M; Labus J; Naliboff B; Lundberg P; Ström M; Mayer EA; Walter SA
    Gastroenterology; 2012 Mar; 142(3):463-472.e3. PubMed ID: 22108191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.
    Johnston JM; Kurtz CB; Macdougall JE; Lavins BJ; Currie MG; Fitch DA; O'Dea C; Baird M; Lembo AJ
    Gastroenterology; 2010 Dec; 139(6):1877-1886.e2. PubMed ID: 20801122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Further characterization of painful constipation (PC): clinical features over one year and comparison with IBS.
    Drossman DA; Morris C; Hu Y; Leserman J; Dalton C; Toner B; Diamante N; Bangdiwala S
    J Clin Gastroenterol; 2008; 42(10):1080-8. PubMed ID: 18949838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bloating and distention in irritable bowel syndrome: the role of visceral sensation.
    Agrawal A; Houghton LA; Lea R; Morris J; Reilly B; Whorwell PJ
    Gastroenterology; 2008 Jun; 134(7):1882-9. PubMed ID: 18455167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abdominal pain impacts quality of life in women with irritable bowel syndrome.
    Cain KC; Headstrom P; Jarrett ME; Motzer SA; Park H; Burr RL; Surawicz CM; Heitkemper MM
    Am J Gastroenterol; 2006 Jan; 101(1):124-32. PubMed ID: 16405544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome.
    Andrae DA; Covington PS; Patrick DL
    Clin Ther; 2014 May; 36(5):663-79. PubMed ID: 24813429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of electroacupuncture at homotopic and heterotopic acupoints on abdominal pain in patients with irritable bowel syndrome: study protocol for a randomized controlled trial.
    Peng Y; You H; Chen X; Chen Y; Yang Y; Huang J; Xu N; Liu J
    Trials; 2018 Oct; 19(1):559. PubMed ID: 30326940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Irritable bowel syndrome: an international study of symptoms in eight countries.
    Gerson CD; Gerson MJ; Awad RA; Chowdhury A; Dancey C; Poitras P; Porcelli P; Sperber A; Wang WA
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):659-67. PubMed ID: 18679069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
    Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
    Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women.
    Chojnacki C; Walecka-Kapica E; Lokieć K; Pawłowicz M; Winczyk K; Chojnacki J; Klupińska G
    Endokrynol Pol; 2013; 64(2):114-20. PubMed ID: 23653274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional constipation masked as irritable bowel syndrome.
    Tosto M; D'Andrea P; Salamone I; Pellegrino S; Costa S; Lucanto MC; Pallio S; Magazzu' G; Guandalini S
    BMC Gastroenterol; 2020 Apr; 20(1):86. PubMed ID: 32252644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.
    Hawrelak JA; Myers SP
    J Altern Complement Med; 2010 Oct; 16(10):1065-71. PubMed ID: 20954962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.
    Mearin F; Caballero AM; Serra J; Brotons C; Tantiñà A; Fort E; Martínez-Cerezo FJ; Perelló A; Sánchez-Antolín G; Rey E; Angós Musgo R; Berdier R; Gómez-Rodríguez B; Clavé P; García-Alonso M; Torán-Monserrat P; Tack J
    Gastroenterol Hepatol; 2019 Mar; 42(3):141-149. PubMed ID: 30612850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome.
    Chapman RW; Stanghellini V; Geraint M; Halphen M
    Am J Gastroenterol; 2013 Sep; 108(9):1508-15. PubMed ID: 23835436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.